from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1060/-

LFCtreatmentdescriptionclass of inhibitor

1.101

Amikacinug/mL Amikacintranslation

1.734

Cap5-10ug/mL Capreomycintranslation

2.328

Rox10-50 ug/mL Roxithromycintranslation

0.379

SM2-5 ug/mL Streptomycintranslation

1.614

Tet5-10 ug/mL Tetracyclinetranslation

0.308

Rif0.2-5ug/mL Rifampicintranscription

-0.703

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.116

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.526

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.147

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.638

Clofazimine10-13 ug/mL Clofaziminerespiration

0.107

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.685

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.529

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.386

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.677

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.189

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.120

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.425

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.117

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.883

KCN5-20 ug/mL Potassium cyaniderespiration

-1.423

NaN30.2-2 mM Sodium aziderespiration

0.286

Nigericin50 uM Nigericinrespiration

-0.971

TRC10-150 ug/mL Triclosanrespiration

-0.148

TRZ10-25 ug/mL Thioridazinerespiration

0.181

Valinomycin0.5-10 uM Valinomycinrespiration

-0.189

ZnSO42 mM ZnSO4respiration

-0.145

menadione6-10 ug/mL Menadionerespiration

-0.317

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.258

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.574

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.332

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.440

NRP_1Non-replicating persistence stage 1dosRassociated

0.461

Amp0.2mg/mL AmpicillincellWall

0.018

Cephalexin20-100 ug/mL CephalexincellWall

0.151

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.083

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.705

EMB10-20 ug/mL EthambutolcellWall

-0.246

Eta12-40 ug/mL EthionamidecellWall

0.205

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.139

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.936

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.213

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.253

BZA0.12 mg/mL BenzamidearomaticAmides

-0.017

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.171

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.551

H2O24 mM hydrogen peroxideDNAdamaging

-0.119

Levo10 ug/mL LevofloxacinDNAdamaging

0.925

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.129

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.031

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.318

UVUV-irradiationDNAdamaging

-0.244

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.037

Antimycin12.5-50 ug/mL Antimycin A?

-0.237

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.022

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.113

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.865

PA8240.2-2 ug/mL PA-824?

-1.080

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.314

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.001

Verapamil50 uM Verapamil?

0.049

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.025

methoxatin10-20 ug/mL Methoxatin?